Tasly Pharmaceutical Group Co., Ltd (SHA:600535)

China flag China · Delayed Price · Currency is CNY
15.17
+0.06 (0.40%)
Apr 29, 2026, 2:55 PM CST
1.68%
Market Cap 22.57B
Revenue (ttm) 8.35B
Net Income (ttm) 1.16B
Shares Out 1.49B
EPS (ttm) 0.78
PE Ratio 19.45
Forward PE 13.37
Dividend 0.31 (2.07%)
Ex-Dividend Date n/a
Volume 15,358,074
Average Volume 10,959,183
Open 15.11
Previous Close 15.11
Day's Range 15.02 - 15.30
52-Week Range 13.45 - 17.69
Beta 0.38
RSI 67.14
Earnings Date Apr 25, 2026

About SHA:600535

Tasly Pharmaceutical Group Co., Ltd, together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers prescription drugs covering various therapeutic areas, including cardiovascular-cerebrovascular, tumor immunity, digestion and metabolism, and neuroscience; over-the-counter drugs; modern TCM; biological drugs; and chemical drugs. It also engages in medical instruments, agriculture, and chain drugstore activities. The company was formerly known as Tianjin Tasly Pharmaceut... [Read more]

Sector Healthcare
Founded 1994
Employees 10,563
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600535
Full Company Profile

Financial Performance

In 2025, SHA:600535's revenue was 8.24 billion, a decrease of -3.08% compared to the previous year's 8.50 billion. Earnings were 1.10 billion, an increase of 15.63%.

Financial Statements

News

There is no news available yet.